Overview
I am a Research Associate and Trial Manager in the Cancer Research theme at the Centre for Trials Research.
Publication
2025
- Russell, N. H. et al., 2025. Treatment intensification with either fludarabine, AraC, G-CSF and idarubicin, or cladribine plus daunorubicin and AraC on the basis of residual disease status in older patients With AML: Results From the NCRI AML18 Trial. Journal of Clinical Oncology 43 (6), pp.694-704. (10.1200/JCO.24.00259)
2022
- Love, S. B. et al., 2022. What is the purpose of clinical trial monitoring?. Trials 23 836. (10.1186/s13063-022-06763-2)
2020
- Pell, B. et al. 2020. PRImary care Management of lower Urinary tract Symptoms in men: protocol for development and validation of a diagnostic and clinical decision support tool (the PriMUS study). BMJ 10 (6) e037634. (10.1136/bmjopen-2020-037634)
2019
- Drew, C. J. G. et al. 2019. Physical activity and exercise outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month trial within cohort evaluation of a physical activity intervention in people with Huntington Disease. Physical Therapy 99 (9), pp.1201-1210. (10.1093/ptj/pzz075)
- Morse, D. J. et al. 2019. Molecular community profiling of the bacterial microbiota associated with denture-related stomatitis. Scientific Reports 9 10228. (10.1038/s41598-019-46494-0)
2018
- Nishio Ayre, W. et al. 2018. Enterococcus faecalis demonstrates pathogenicity through increased attachment in an ex vivo polymicrobial pulpal infection. Infection and Immunity 86 (5) e00871-17. (10.1128/IAI.00871-17)
2017
- Mariyaselvam, M. Z. et al., 2017. Endotracheal tubes and fluid aspiration: An in vitro evaluation of new cuff technologies. BMC Anesthesiology 17 36. (10.1186/s12871-017-0328-0)
2016
- Benjamin, T. et al., 2016. A novel approach to antibiofilm susceptibility testing using a thermo-reversible matrix. Journal of Wound Care 25 (2), pp.62-67. (10.12968/jowc.2016.25.2.62)
- Jordan, R. P. C. et al. 2016. An assessment of early colonisation of implant-abutment metal surfaces by single species and co-cultured bacterial periodontal pathogens. Journal of Dentistry 53 , pp.64-72. (10.1016/j.jdent.2016.07.013)
2014
- Sands, K. M. et al. 2014. Mechanisms of augmented growth of Pseudomonas aeruginosa mediated by Candida albicans [Letter]. Critical Care Medicine 42 (3), pp.e256. (10.1097/CCM.0000000000000113)
Articles
- Benjamin, T. et al., 2016. A novel approach to antibiofilm susceptibility testing using a thermo-reversible matrix. Journal of Wound Care 25 (2), pp.62-67. (10.12968/jowc.2016.25.2.62)
- Drew, C. J. G. et al. 2019. Physical activity and exercise outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month trial within cohort evaluation of a physical activity intervention in people with Huntington Disease. Physical Therapy 99 (9), pp.1201-1210. (10.1093/ptj/pzz075)
- Jordan, R. P. C. et al. 2016. An assessment of early colonisation of implant-abutment metal surfaces by single species and co-cultured bacterial periodontal pathogens. Journal of Dentistry 53 , pp.64-72. (10.1016/j.jdent.2016.07.013)
- Love, S. B. et al., 2022. What is the purpose of clinical trial monitoring?. Trials 23 836. (10.1186/s13063-022-06763-2)
- Mariyaselvam, M. Z. et al., 2017. Endotracheal tubes and fluid aspiration: An in vitro evaluation of new cuff technologies. BMC Anesthesiology 17 36. (10.1186/s12871-017-0328-0)
- Morse, D. J. et al. 2019. Molecular community profiling of the bacterial microbiota associated with denture-related stomatitis. Scientific Reports 9 10228. (10.1038/s41598-019-46494-0)
- Nishio Ayre, W. et al. 2018. Enterococcus faecalis demonstrates pathogenicity through increased attachment in an ex vivo polymicrobial pulpal infection. Infection and Immunity 86 (5) e00871-17. (10.1128/IAI.00871-17)
- Pell, B. et al. 2020. PRImary care Management of lower Urinary tract Symptoms in men: protocol for development and validation of a diagnostic and clinical decision support tool (the PriMUS study). BMJ 10 (6) e037634. (10.1136/bmjopen-2020-037634)
- Russell, N. H. et al., 2025. Treatment intensification with either fludarabine, AraC, G-CSF and idarubicin, or cladribine plus daunorubicin and AraC on the basis of residual disease status in older patients With AML: Results From the NCRI AML18 Trial. Journal of Clinical Oncology 43 (6), pp.694-704. (10.1200/JCO.24.00259)
- Sands, K. M. et al. 2014. Mechanisms of augmented growth of Pseudomonas aeruginosa mediated by Candida albicans [Letter]. Critical Care Medicine 42 (3), pp.e256. (10.1097/CCM.0000000000000113)